Former Commissioners Push For Sharpless Nomination, Confirmation
Five former US FDA leaders and many stakeholder groups say Acting Commissioner Norman Sharpless should be the next permanent commissioner.
You may also be interested in...
The MD Anderson Cancer Center administrator's lack of significant government administration experience may inspire questions during the confirmation process.
Assistant HHS secretary for health has led policy development for several offices since his 2018 confirmation and also has industry and clinical experience.
Data Manipulation Not Common, But Happens "More Than I Would Have Expected," US FDA's Sharpless Says
As fallout from the Novartis Zolgensma data manipulation incident continues, US FDA acting commissioner Norman Sharpless notes that "at some level we have to trust the sponsors."